2 nd Announcement - 2016 International Conference on Diabetes

Transcription

CONTENTS
Invitation
3
Organization
4
Timetable
5
Scientific program
6
Registration
14
Oral presentation / Poster exhibition
15
Accommodation
17
Transportation
18
Invitation
Dear Colleagues,
On behalf of the Korean Diabetes Association (KDA), it is our great honor to invite you to
the 2016 International Conference on Diabetes and Metabolism (ICDM), which will be held
in Seoul, Korea from October 13th to 15th, 2016, the most beautiful season in this country.
The ICDM has been successfully held with thousands of participants from the globe
since its first inception in 2011. The 2016 ICDM will encompass a variety of up-to-date
knowledge on diabetes and metabolism. There will be three plenary sessions, 14 main
symposia, corporate symposia, and oral presentation. This year’s ICDM will be also featured
by Best of EASD session and KDA-Steno session collaboratively organized by the KDA and
Steno Diabetes Center of Denmark. Plenary speakers are world renowned scholars in the
field of diabetes and metabolism, who will share their state-of-the-art knowledge and
insight. In the main symposia, hot topics in various aspects of diabetes and metabolism
from basic science to clinical therapeutics will be covered.
We would like to cordially invite you to join the 2016 ICDM. We believe, in this fabulous
scientific meeting, that you can enjoy Seoul, home to beautiful historical sites, savory
foods, internationally popular modern entertainments, and more.
We look forward to meeting you in the 2016 ICDM.
Sincerely yours
Yong-Wook Cho, M.D., Ph.D.
Moon Kyu Lee, M.D., Ph.D.
President
Korean Diabetes Association
Chairman, Board of Directors
Korean Diabetes Association
2016 International Conference on Diabetes and Metabolism
·3
Organization
▼
Organizing committee
Chairman
Secretary general
Publication
Education
Treasurer
▼
Yong-Wook Cho
Kyong Soo Park
Sung Rae Kim
Dae Jung Kim
Joong Yeol Park
Chul-Hee Kim
Kyong Soo Park
Young Min Cho
In-Kyung Jeong
Jae Hyeon Kim
Min Seon Kim
Young-Bum Kim
Dae Ho Lee
Min Ho Shong
Yang Ho Kang
Jae Hyun Kim
Nan Hee Kim
Bo Kyung Koo
Jung Hyun Noh
Jang Won Son
Ha Il Kim
Jaetaek Kim
Sang Yong Kim
Byung-Wan Lee
Keun-Gyu Park
Dae-Kyu Song
Bong Yun Cha
Min Young Chung
Bo Wan Kim
Tae Wha Kim
Young Seol Kim
Hyun Chul Lee
Ho Young Son
Dong Seop Choi
Kap Bum Huh
Jin Woo Kim
Yong Ki Kim
Sun Woo Kim
Hun Ki Min
Soon Hyun Shinn
Juliana C.N. Chan
Takashi Kadowaki
Jianping Weng
Robert A. Harris
David D. Moore
Local advisory board
Members
▼
Co-Chairman
Scientific program
International liaison
Public relation
Auditor
Scientific program committee
Chair
Secretary
Members
▼
Moon Kyu Lee
Jae Hyeon Kim
Kyu Chang Won
Dong Jun Kim
Young Sun Hong
Hong-Sun Baek
Young Kil Choi
Sung Koo Kang
Kwang Won Kim
Young Kun Kim
Hong Kyu Lee
Sung Woo Park
Hyung Joon Yoo
International advisory board
E. Dale Abel
Linong Ji
Wannee Nitiyanant
4 · 2016 International Conference on Diabetes and Metabolism
Timetable
* Sessions in Simultaneous Interpretation (EN to KR)
st
1 day (Thursday 13 October, 2016)
Room
Convention Hall A, 4F Convention Hall B, 4F Convention Hall C, 4F
Time
Clinical diabetes and
therapeutics
Research group on
15:00-17:00 Beta Cell Biology and
Islet Transplantation
17:00~17:30
Emerald Hall A, 3F
Emerald Hall B, 3F
Diabetic
complications
Islet biology &
insulin secretion/
Epidemiology &
genetics
Behavioral medicine/
Insulin action/Obesity/
education/Clinical
Integrated physiology
nutrition/Self-care
Research group
on Clinical Data
Standardization for
Diabetes Research
Research group on
Diabetic Neuropathy
Research group on Research group on
Genetics
Diabetes in Old Age
Sulwon lecture
17:30~18:00 Satellite symposium1 Satellite symposium 2 Satellite symposium 3
18:00~
Welcome reception (Outdoor garden, 2F, Hotel)
nd
2 day (Friday 14 October, 2016)
07:30~08:30
Breakfast
symposium 1
Breakfast
symposium 2
09:00~11:00
S1 Clinical diabetes
and therapeutics 1
*S2 Behavioral
medicine/education
11:00~11:20
Opening address
11:30~12:10
*Plenary lecture 1
12:10~12:30
S5 Islet biology &
insulin secretion
Break (Poster viewing)
Luncheon
symposium 1
14:00~14:40
Luncheon
symposium 2
Luncheon
symposium 3
Luncheon
symposium 4
*Plenary lecture 2
14:40~15:00
Coffee Break
Diabetes and
15:00~16:00 metabolism journal
session
16:00~18:00
S4 Diabetic
complications 1
-Acute
Coffee break
11:20~11:30
12:30~14:00
S3 Insulin action
and therapeutics 2
18:00~
Oral presentations
*S7 Clinical nutrition
KDA-Steno joint
symposium
S8 Diabetic
complications 2
-Chronic
S9 Epidemiology &
genetics
Dinner and art performance (Grand ballroom, 2F, Hotel)
3rd day (Saturday 15 October, 2016)
07:00~08:00
Breakfast
symposium3
Breakfast
symposium 4
08:30~10:30
and therapeutics 3
*Committee of the
Camp
10:30~10:50
Committee of
Clinical Practice
Guideline
Best of EASD
symposium 1
S14 Diabetic
complications 3
-Chronic
Best of EASD
symposium 2
Coffee break
10:50~11:30
*Plenary lecture 3
11:30~11:50
11:50~13:00
S11 Obesity
Luncheon
symposium 5
Luncheon
symposium 6
13:00~14:00
Luncheon
symposium 7
Oral presentations
14:00~16:00
Research group on
Gestational Diabetes
16:00~
Closing ceremony
*S12 Self-care
S13 Integrated
physiology
·5
Scientific program
Thursday 13 October
15:00~17:00
Convention
hall A
Research group on Beta Cell Biology and Islet Transplantation
Islet xenotransplantation: recent progress and current perspectives
RG1-1 Why islet xenotransplantation in diabetes?
Kwang-Won Kim (Gachon University, Korea)
RG1-2 Current status of islet xenotransplantation
Chung-Gyu Park (Seoul National University, Korea)
RG1-3 Avoidance strategy for xeonogenic immune reaction using highly advanced surface modification
technique
Jee-Heon Jeong (Yeungnam University, Korea)
RG1-4 Xenotransplantation and zoonotic infection
Eung Soo Hwang (Seoul National University, Korea)
15:00~17:00
Convention
hall B
Research group on Clinical Data Standardization for Diabetes Research
Platforms for patient centered clinical research
RG2-1 Introduction of iCReaT
Hae Rim Choi (National Research Institute of Health, Korea)
RG2-2 ABLE: de-identified clinical data search, review, and extraction system
Soo-Yong Shin (University of Ulsan, Korea)
RG2-3 Introduction of KNDP data management house, KDMH Sang Youl Rhee (Kyung Hee University, Korea)
15:00~17:00
Convention
hall C
Research group on Diabetic Neuropathy
Paradigm shift of management in diabetic peripheral neuropathy
RG3-1 Nonpharmacologic approach for managing diabetic polyneuropathy
Jee Youn Moon (Seoul National University, Korea)
RG3-2 Current update on pharmacologic management of diabetic neuropathy
Jee Young Oh (Konkuk University, Korea)
RG3-3 Comprehensive management of intractable DPN
Chong Hwa Kim (Sejong general hospital, Korea)
RG3-Panel Panel discussion
Ji Hyun Lee (Daegu Catholic University, Korea), Jung Min Lee (The Catholic University of Korea, Korea),
Mi Kyoung Park (Dong-A University, Korea)
15:00~17:00
Emerald
Hall A
Research group on Genetics
Genomics at the out-front of patient care
RG4-1 Clinical exome sequencing on early onset diabetes patients
Soo Heon Kwak (Seoul National University, Korea)
RG4-2 TBD
Richard Watanabe (University of Southern California, USA)
RG4-3 Origins and functional consequences of mitochondrial DNA mutations in human cancer
Young Seok Ju (KAIST, Korea)
RG4-4 Characteristics of apolipoprotein gene clusters on chromosome 11 in Koreans and the association with
plasma triglyceride level
Joo Hon Sung (Seoul National University, Korea)
15:00~17:00
Emerald
Hall B
Research group on Diabetes in Old Age
Frailty in diabetes
RG5-1 The applications of individualized health management system using advanced medical information
technology in elderly patients with diabetes
Soo Lim (Seoul National University, Korea)
RG5-2 Diabetes, vascular cognitive impairment and AD
Jee Hyang Jeong (Ewha Womans University, Korea)
RG5-3 Frailty in diabetes
Jung Hyun Noh (Inje University, Korea)
17:00~17:30
Convention
hall A
Sulwon lecture
TBD (TBD)
17:30~18:00
Convention
hall A
Satellite symposium 1 Sponsored by JW Pharmaceutical
Postprandial hyperglycemia and incretin-based combination therapy in type 2 diabetes
Yong-Ho Lee (Yonsei University, Korea)
17:30~18:00
Convention
hall B
Satellite symposium 2 Sponsored by Astellas
Update on the safety of SGLT-2 inhibitor in elderly type 2 diabetes patients; focusing on ipragliflozin’s final
analysis of STELLA-ELDER
Chong Hwa Kim (Sejong general hospital, Korea)
17:30~18:00
Convention
hall C
Satellite symposium 3 Sponsored by Pfizer
The latest updates in the management of dyslipidemia in the diabetics: what to consider what not
Suk Chon (Kyung Hee University, Korea)
18:00
Outdoor
garden,
2F, Hotel
Welcome reception
Friday 14 October
07:30~08:30
Convention
hall A
Breakfast symposium 1 Sponsored by Astrazeneca
Benefit your T2DM patients by early initiation of metformin/SGLT-2I combination treatment
Mi Kyung Kim (Inje University, Korea)
07:30~08:30
Convention
hall B
Breakfast symposium 2 Sponsored by Novonordisk
SWITCH: the answer to better glycaemic control safely
Roger Chen (Concord Repatriation General Hospital, Australia)
09:00~11:00
Convention
hall A
S1 Clinical diabetes and therapeutics 1
Updates on new drugs for type 2 diabetes
S1-1 SGLT 2 inhibition: is there a downside?
Merlin C Thomas (Baker IDI Heart and Diabetes Institute, Australia)
S1-2 Cardiovascular & renal outcomes of incretin-based therapy
Kyung Mook Choi (Korea University, Korea)
S1-3 GLP-1 receptor agonists: similarities and differences
Chang Hee Jung (University of Ulsan, Korea)
S1-4 Ultra-long acting Insulin: How long should it be?
Hyuk-Sang Kwon (The Catholic University of Korea, Korea)
09:00~11:00
Convention
hall B
S2 Behavioral medicine/education
Current management of type 1 diabetes in real clinical practice
S2-1 Clinical practice guidelines in management of type 1 diabetic patients
Dong-Hyeok Cho (Chonnam National University, Korea)
S2-2 Education programs for the better self-management of children and adolescents with type 1 diabetes
Eun Kyung Kwon (Samsung Medical Center, Korea)
S2-3 Dietary intervention in patients with type 1 diabetes
Mi Ra Rho (Boramae Medical Center, Korea)
S2-4 Psycosocial understanding and diabetes education for children with type 1 diabetes mellitus
Myeoung Sook Lee (Dongsan Medical Center, Korea)
·7
09:00~11:00
Convention
hall C
S3 Insulin action
mTOR and insulin action
S3-1 Overview of mTOR signaling
Mee Sup Yoon (Gachon University, Korea)
S3-2 mTOR signaling network in skeletal myogenesis
Jie Chen (University of Illinois, USA)
S3-3 PHLPPs - necessary negative regulators of hepatic insulin signaling
Utpal B. Pajvani (Columbia University, USA)
S3-4 Control of adipogenesis by S6K1-mediated epigenetic modifications
Jeung-Whan Han (Sungkyunkwan University, Korea)
09:00~11:00
Emerald
Hall A
S4 Diabetic complications 1-Acute
Improving hypoglycemia in patients with diabetes
S4-1 Incretin therapy and hypoglycemia
Daisuke Yabe (Kyoto University, Japan)
S4-2 Reversal of hypoglycemic unawareness with islet transplantation
Kun-Ho Yoon (The Catholic University of Korea, Korea )
S4-3 Updates in real-time CGM and artificial pancreas
Sang-Man Jin (Sungkyunkwan University, Korea)
S4-4 Prevention of hypoglycemia-induced neuronal death
Sang Won Suh (Hallym University, Korea)
09:00~11:00
Emerald
Hall B
S5 Islet biology & insulin secretion
Toward beta cell replacement for diabetes
S5-1 Maturation of human embryonic stem cell derived beta cells
Metthias Hebrok (University of California San Francisco, USA)
S5-2 Differentiation of human induced pluripotent stem cells into insulin-producing cells
Ji Won Kim (The Catholic University of Korea, Korea)
S5-3 Making mature human islet cells from stem cells to model disease and treat diabetes
Timothy Kieffer (University of British Columbia, Canada)
S5-4 Glucose responsiveness of islet-like organoids generated from human pluripotent stem cells
Yong-Mahn Han (KAIST, Korea)
11:00~11:20
3F & 4F
Lobby
Coffee break
11:20~11:30
Convention
hall A, B, C
Opening address
11:30~12:10
Convention
hall A, B, C
Plenary lecture 1
Cross-species genetic mapping of targets in metabolism and aging
Johan Auwerx (École Polytechnique Fédérale de Lausanne, Switzerland)
12:10~12:30
12:30~14:00
Convention
hall A
Luncheon symposium 1 Sponsored by Lilly
Advances in the treatment of type 2 diabetes: a new once-weekly GLP-1 receptor agonist, dulaglutide
Kyu Yeon Hur (Sungkyunkwan University, Korea)
12:30~14:00
Convention
hall B
Luncheon symposium 2 Sponsored by Yuhan
Empagliflozin: deep diving into EMPA-REG outcome(CV & renal)
Sung Hoon Yu (Hallym University, Korea)
12:30~14:00
Convention
hall C
Luncheon symposium 3 Sponsored by Sanofi Aventis
Practical insulin titration: let your patient take the helm
12:30~14:00
Emerald
Hall A
Luncheon symposium 4 Sponsored by LG
A new and powerful treatment option for dyslipidemia in type 2 diabetes mellitus
Eun-Gyoung Hong (Hallym University, Korea)
14:00~14:40
Convention
hall A, B, C
Plenary lecture 2
Metabolic surgery for type 2 diabetes: experience from Asia Wei-Jei Lee (Min-Sheng General Hospital, Taiwan)
14:40~15:00
3F & 4F
Lobby
Coffee break
15:00~16:00
Convention
hall A
Diabetes and metabolism journal session
Special oral session with DMJ
CS1-1 Normal glucose tolerance with a high 1-hour postload plasma glucose level exhibits decreased β-cell
function similar to impaired glucose tolerance
Tae Jung Oh (Seoul National University, Korea)
CS1-2 Changing clinical characteristics according to insulin resistance and insulin secretion in newly diagnosed
type 2 diabetic patients in Korea
Jang Won Son (The Catholic University of Korea, Korea)
CS1-3 Cardiovascular disease predicts severe hypoglycemia in patients with type 2 diabetes
Jae Seung Yun (The Catholic University of Korea, Korea)
CS1-4 The insulin resistance but not the insulin secretion parameters have changed in the Korean population
during the last decade
Hae Kyung Yang (The Catholic University of Korea, Korea)
CS1-5 Insulin initiation in insulin naïve Korean type 2 diabetic patients inadequately controlled on oral
antidiabetic drugs in real world practice: the modality of insulin treatment evaluation (MOTIV) study
In Joo Kim (Pusan National University, Korea)
16:00~18:00
Convention
hall A
Recent update on CVD risk management in type 2 diabetes
S6-1 Management of cardiovascular disease in patients with diabetes
Bon-Kwon Koo (Seoul National University, Korea)
Sung Ha Park (Yonsei University, Korea)
S6-2 Update on blood pressure goals in T2DM (post-SPRINT era)
Woo Je Lee (University of Ulsan, Korea)
S6-3 Are recent cholesterol treatment guidelines still controversial?
Arya M. Sharma (University of Alberta, Canada)
S6-4 Obesity: drug or surgery
S6-5 Glucose control for prevention of cardiovascular disease (lesson from large clinical trials)
Sang Yong Kim (Chosun University, Korea)
16:00~18:00
Convention
hall B
S7 Clinical nutrition
Nutrition in diabetes prevention
Dae Jung Kim (Ajou University, Korea)
S7-1 Food, nutrient and risk of diabetes
S7-2 Dietary components and nutritional strategies in the prevention and management of type 2 diabetes
Yoon Ju Song (The Catholic University of Korea, Korea)
S7-3 Theory-based nutrition intervention for preventing diabetes Hyunjung Lim (Kyung Hee University, Korea)
S7-4 Diabetes prevention in Australia: 10 years results and experience
James A Dunbar (Deakin University, Australia)
Young Min Cho (Seoul National University, Korea)
·9
16:00~18:00
Convention
hall C
KDA-Steno joint symposium Sponsored by Novo Nordisk®
Gut microbiome and diabetes
SI1-1 Omics, technologies and the diabetes clinic of the future John J Nolan (Steno Diabetes Center, Denmark)
SI1-2 Gut barrier dysfunction and microbial dysbiosis in high fat induced obesity
Kyu Yeon Hur (Sungkyunkwan University, Korea)
SI1-3 The effect of host genetics on gut microbiota and metabolic syndromes
Gwang Pyo Ko (Seoul National University, Korea)
SI1-4 A potential role for the gut microbiota in diabetic kidney complications
Peter Rossing (Steno Diabetes Center, Denmark)
SI1-5 The impact of the gut microbiome on metabolic health and disease
Torben Hansen (Copenhagen University, Denmark)
16:00~18:00
Emerald
Hall A
S8 Diabetic complications 2-Chronic
Novel experimental targets and therapeutic strategies for diabetic vascular complications
S8-1 Diabetic kidney disease; past, present and future
Katalin Susztak (University of Pennsylvania, USA)
S8-2 Discovery and development of PAI-1 inhibitors: potential clinical implications
Toshio Miyata (Tohoku University, Japan)
S8-3 Mechanism of diabetic microvasculopathy, high jagged1 and low notch
Hyo-Soo Kim (Seoul National University, Korea)
S8-4 A toe in the door of translational research on diabetic retinopathy
Jeong Hun Kim (Seoul National University, Korea)
16:00~18:00
Emerald
Hall B
S9 Epidemiology & genetics
Pharmacogenomics in type 2 diabetes
S9-1 Pharmacogenomics and personalized drug therapy
Kyung-Sang Yu (Seoul National University, Korea)
S9-2 Personalized medicine focusing PPARG
Richard Watanabe (University of Southern California, USA)
S9-3 Whole exome sequencing revealed variants associated with dependency on sulfonylureas in type 2
diabetes
Hye Seung Jung (Seoul National University, Korea)
S9-4 Pharmacogenomics for the anti-platelet drug
Su-Jun Lee (Inje University, Korea)
18:00
Dinner and art performance
Grand ballroom,
2F, Hotel
Saturday 15 October
07:00~08:00
Convention
hall A
Breakfast symposium 3 Sponsored by Ildong
New anti-obesity drug
07:00~08:00
Convention
hall B
Breakfast symposium 4 Sponsored by Daewoong
The optimized DPP-4 inhibitor for type 2 diabetes: focus on recent clinical results of gemigliptin in Korea
Soo Lim (Seoul National University, Korea)
Kyung Mook Choi (Korea University, Korea)
08:30~10:30
Convention
hall A
Staging and definition of metabolic disease
S10-1 Obesity staging to predict mortality in a subjects with T2D
Arya M. Sharma (University of Alberta, Canada)
S10-2 Rationale and implications of a β-cell-centric classification of diabetes
Stanley Schwartz (University of Pennsylvania, USA)
S10-3 MHO(metabolically healthy obesity): reality or phantom-pro&con
Sin Gon Kim (Korea University, Korea)
S10-4 MHO(metabolically healthy obesity): reality or phantom-pro&con
Sung Hee Choi (Seoul National University, Korea)
08:30~10:30
Convention
hall B
Transition to adulthood in type 1 diabetes
CS2-1 Cognitive behaviour therapy to improve psychosocial wellbeing in youth with type 1 diabetes
Hye-Jung Shin (National Medical Center, Korea)
CS2-2 Transition to adult care for youth with type 1 diabetes
Fergus J. Cameron (University of Melbourne, Australia)
CS2-3 Management of adults with type 1 diabetes in Korea: today and tomorrow
Jae Hyeon Kim (Sungkyunkwan University, Korea)
CS2-4 A multicenter registry study of type 1 diabetes mellitusin Guangdong, China
Daizhi Yang (Sun Yat-sen University, China)
08:30~10:30
Convention
hall C
S11 Obesity
Central and peripheral interplay for energy and glucose metabolism
Young-Bum Kim (Harvard University, USA)
S11-1 Control of glycemia by the CNS
Jong Woo Shon (KAIST, Korea)
S11-2 Regulation of food intake by hypothalamic serotonin circuit
S11-3 Role of gut afferent nervous system in communicating nutritional information to the brain
Gary J. Schwartz (Albert Einstein University, USA)
S11-4 Central dopaminergic system regulates energy balance and BAT function
Ki Woo Kim (Yonsei-Wonju University, Korea)
08:30~10:30
Emerald
Hall A
Committee of Clinical Practice Guideline
Clinical Guidelines for Diabetes in Asia
CS3-1 Screening and diagnosis of diabetes mellitus in Taiwan
Hung-Yuan Li (National Taiwan University, Taiwan)
CS3-2 Glycemic targets for elderly patients with diabetes in Japan
Masakazu Haneda (Asahikawa University, Japan)
CS3-3 Cardiovascular disease risk estimation and lipid management in Chinese diabetes mellitus
Tao Yang (Nanjing University, China)
CS3-4 Clinical practice guidelines to guide a system approach to diabetes care
Ip Tim Lau (Tseung Kwan O Hospital, Hong Kong)
CS3-5 The process of developing 2015 Clinical Practice Guideline of Korean Diabetes Association
Seung-Hyun Ko (The Catholic University of Korea, Korea)
08:30~10:30
Emerald
Hall B
Best of EASD symposium 1 Sponsored by Novartis
Highlights from 2016 EASD Annual Meeting
SI2 TBD
Richard Holt (University of Southampton, UK)
· 11
10:30~10:50
3F & 4F
Lobby
Coffee break
10:50~11:30
Convention
hall A, B, C
Plenary lecture 3
The pivotal role of pyruvate dehydrogenase complex flux in cellular energy metabolism
In-Kyu Lee (Kyungpook National University, Korea)
11:30~11:50
11:50~13:00
Convention
hall A
Luncheon symposium 5 Sponsored by ChongKunDang
Changing characteristics of diabetes in Korea and insulin resistance
11:50~13:00
Convention
hall B
Luncheon symposium 6 Sponsored by Takeda
CV outcomes of alogliptin in T2DM patients: from free of CVD history to the highest-CV risk
Hyuk-Sang Kwon (The Catholic University of Korea, Korea)
11:50~13:00
Convention
hall C
Luncheon symposium 7 Sponsored by Dong-A ST
Efficacy and safety of the new DPP-4 inhibitor evogliptin
14:00~16:00
Convention
hall A
Research group on Gestational Diabetes
Obesity & diabetes in pregnancy
RG6-1 β-cell adaptation in obesity and pregnancy
Hail Kim (KAIST, Korea)
RG6-2 Prediction and prevention of gestational diabetes mellitus in obese women
Kyung-Soo Kim (CHA University, Korea)
RG6-3 Gestational weight gain in normal and diabetic pregnancy: it should be same or different?
Min Hyoung Kim (Dankook University, Korea )
RG6-4 Can metformin improve pregnancy outcomes in obese and diabetic women
Kyung Wook Kim (Dongtan Jeil Womens Hospital, Korea)
14:00~16:00
Convention
hall B
S12 Self-care
Patient-centered educational strategies for managing diabetes
S12-1 From a physician-centered approach to story-centered care
Masatake Sugimoto (Tokyo Adventist Hospital, Japan)
S12-2 Community prediabetes / diabetes self-care education in nutrition, exercise and lifestyle change skills
Hannah Mitter (Circle of Community Health Educators International, USA)
TBD (TBD)
Jong Chul Won (Inje University, Korea)
14:00~16:00
Convention
hall C
S13 Integrated physiology
Systemic control of energy balance
S13-1 Bioenergetic modulation in rare and common disease
Rodrigue Rossignol (INSERM, France)
S13-2 Modulation of autophagy as a new therapeutic modality against metabolic syndrome
Myung-Shik Lee (Yonsei University, Korea)
S13-3 Microbiota-generated metabolites improve muscle function via mitophagy
Dongyeol Ryu (École Polytechnique Fédérale de Lausanne, Switzerland)
S13-4 Regulation of systemic glucose homeostasis by Th2 cytokines
Min Ho Shong (Chungnam National University, Korea)
14:00~16:00
Emerald
Hall A
S14 Diabetic complications 3-Chronic
Deciphering diabetic complications one piece at a time
S14-1 Diabetic neuropathy in brain: time for a paradigm shift
Seong-Su Moon (Dongguk University, Korea)
S14-2 Extent & severity of coronary atherosclerosis in asymptomatic diabetic individuals
Ki Yuk Chang (The Catholic University of Korea, Korea)
S14-3 My sweetheart is broken: role of glucose in diabetic cardiomyopathy
Adam R. Wende (University of Alabama, USA)
S14-4 Deficiency of endothelial transcription factor Sox17 causes intracranial aneurysm
Seung Joo Lee (University of Ulsan, Korea)
14:00~16:00
Emerald
Hall B
Best of EASD symposium 2 Sponsored by Novartis
Highlights from 2016 EASD Annual Meeting
SI3 TBD
Michael Trenell (Newcastle University, UK)
· 13
Registration
Early-registration has the advantage of discount. After the deadline it is not available to register.
▼
Registration fee
Classification
Regular
rate
Full registration
One-day
registration
Early-registration (~31 August 2016)
Domestic
International
Member
Non-member
USD 100
USD 150
USD 150
Reduced rate
USD 80
USD 120
USD 50
USD 70
USD 100
On-site registration 13~15 October 2016
Domestic
International
Member
Non-ember
USD 120
USD 170
USD 200
USD 100
USD 100
USD 70
Low income countries : USD 50
USD 140
USD 150
USD 90
USD 150
* Regular rate: Medical doctors, Scientists
* Reduced rate: Healthcare professionals other than medical doctors (nurses, dietitian, pharmacist, others), Residents, Students
* Low income countries https://datahelpdesk.worldbank.org/knowledgebase/articles/906519
* Resident / Student registration requires a written letter on their affiliation letterhead, with the statement that the registered
person is a resident / student at the time of the conference, to be signed by the registrant‘s advisor (Professor, Supervisor,
etc.). This letter ought to be sent to the diabetes@kams.or.kr, with a scanned PDF email attachment.
* The KDA members aged 65 or older are eligible for free registration. In this case they must make early registration.
* A confirmation of registration will be sent you automatically via e-mail upon receipt of your completed registration form and
the full payment. The payment receipt can be printed immediately after completing the online registration.
▼
▼
Dinner on Friday 14 October 2016
(* Note that the Dinner fee is NOT refundable)
Classification
Early registration
On-site registration
Dinner
USD 10
USD 20
Payment methods
• Credit Only: Cash is not acceptable method.
• Vendors: VISA / Master / JCB (AMEX, UnionPay, etc. are not accepted)
• Credit processing fee must be paid by registrants.
▼
Cancellation and refund policy
The organizing committee will refund the registration fee according to the following policy.
After the official deadline application for cancellation and refund will not be accepted.
From 1 September 2016 registration payment cannot be refunded.
- A request for cancelling registration must be pre-notified in writing to the secretariat by e-mail or fax.
- Cancelling registration by phone is not accepted.
- To transfer registration fee to another is not allowed.
Oral presentation / Poster exhibition
• Notification of abstract acceptance : 26 August 2016
▼
Oral presentation
Oral presenters are supposed to completely submit their slide-deck in advance. However some authors may
re-upload their presentation slides or polish up their works onsite. Due to the fact that each of the allotted
presentation time is rapidly and shortly runs authors must visit the speaker’s preview room at least 2 hours before.
• Date : 14 October 2016, 15:00~16:00 & 15 October 2016, 13:00~14:00
• Place : Convention hall & Emerald hall
• Slides format : MS-powerpoint only
• Slides submission to diabetes@kams.or.kr
▼
Categories
Behavior, nutrition, education & exercise
Diabetes education case
Insulin secretion and action
Macrovascular complications
Metabolic syndrome & prediabetes
▼
Clinical diabetes
Epidemiology / genetics
Integrated physiology / obesity
Microvascular complications
Therapeutics of diabetes
Poster exhibitions
• Date : 14 ~ 15 October
• Place : Diamond hall, 3F, Convention center
• Mounting : Before 9:00, 14 October 2016
• Removal : After 16:00, 15 October 2016
• Poster size : 90cm (W) X 140cm (L)
• Language : English
· 15
Accommodation
▼
Grand Hilton Seoul
• Address : 201-1 Hongeun-Dong, Seodaemun-Ku, Seoul, 120-710, South Korea
[ 353 Yeonhui-ro, Seodaemun-gu, Seoul, 120-710, South Korea ]
• Website : http://www3.hilton.com/en/hotels/south-korea/grand-hilton-seoul-hotel-SELGRHI/index.html
Single
Special rates
(Inclusive of VAT & service charge)
KRW 254,100
Twin
KRW 254,100
Double
Executive floor room
(+1 Breakfast, EFL Lounge Only)
2 Bedroom (3 PAX available)
KRW 254,100
KRW 309,760
KRW 367,840
(Optional)
KRW 29,040
Room type
Hotel
Grand Suite
Breakfast
▼
Tmark Hotel Myeongdong
• Phone : +82-2-736-1234
• Address : 65-1, Gyeonji-dong, Jongno-gu, Seoul
• Website : http://www.tmarkhotel.com
Room type
Special rate
Double
Weekdays (sun-thu): KRW 119,000
Weekend (fri-sat): KRW 152,000
Twin
▼
Aventree Hotel Jongno
• Phone : +82-2-736-1234
• Address : 65-1, Gyeonji-dong, Jongno-gu, Seoul
• Website : http://www.aventreehotel.com
Room type
Standard twin
▼
Special rate
ibis Ambassador Insadong
• Phone : +82-2-6730-1101
• Address : 31, Samil-daero 30-gil, Jongno-gu, Seoul
• Website : https://ibis.ambatelen.com/insadong/main.amb
Room type
Special rate
Double
Twin
KRW 314,600
KRW 251,680
Transportation
▼
Incheon International Airport --> Grand Hilton Seoul Hotel
• Airport Limousine
Get on at
Distance
5B or12A
56 km
For more information: http://www.airportlimousine.co.kr/
Travel time
Fare
90 minutes
Approx. USD 15
• Metro
Get on at
Distance
Travel time
Incheon Int’l Airport
100 minutes
Approx. USD 5
1. Get on the Airport Express Line at Incheon Int’l Airport Station
2. Get off at the Digital Media City Station to transfer
3. Get on the Line 6 (Brown) which goes to Bulgwang Station
4. Get off at the Bulgwang Station to transfer
5. Get on the Line 3 (Orange) which goes to Hongje Station
6. Get off at the Hongje Station and go out through Exit 4 to walk to the Venue (15 minutes walk distance)
• Taxi
▼
Get on at
Distance
Travel time
Fare
4C
56 km
60 minutes
Approx. USD 60
Gimpo International Airport --> Grand Hilton Seoul Hotel
• Bus
Get on at
Distance
Travel time
Fare
Gimpo Airport Bus Stop
19.47 km
75 minutes
Approx. USD 1.2
1. Walk to the Gimpo Airport Bus Stop (2 minutes walk distance)
2. Get on the Blue Line Bus # 601 at Gimpo Airport Bus Stop
3. Get off at the Yousei University Bus Stop to transfer
4. Get on the the Green Line # 567 which goes to the Hongeun Hyundai Apartment Bus Stop
5. Get off at the Hongeun Hyundai Apartment Bus Stop
6. Walk to the Venue (4 minutes walk distance)
• Metro
Get on at
Distance
Travel time
Fare
Gimpo Int’l Airport Station
21 km
65 minutes
Approx. USD 1.2
1. Get on the Airport Express Line at Incheon Int’l Airport Station
2. Get off at the Digital Media City Station to transfer
3. Get on the Line 6 (Brown) which goes to Bulgwang Station
4. Get off at the Bulgwang Station to transfer
5. Get on the Line 3 (Orange) which goes to Hongje Station
6. Get off at the Hongje Station and go out through Exit 4 to walk to the Venue (15 minutes walk distance)
• Taxi
Get on at
Gimpo Int’l Airport
Distance
21 km
Travel time
40 minutes
Fare
Approx. USD 11
• Hotel Pick-up Service
It is available for using Grand Hilton Hotel pick-up service. If you want the service, please book in advance through
the hotel reservation department.
- Fare : ICN -> HTL KRW 136,500 for 3 pax including luggage
GMP -> HTL KRW 94,500 for 3 pax including luggage
- Contact information
Tel : +82-2-3216-5656, +82-2-2287-8427~9 / Email :reservation.grandseoul@hilton.com, grandseoul@hilton.com
· 17

2 nd Announcement - 2016 International Conference on Diabetes

Transcription

Similar documents

Evaluation of the German Diabetes Risk Score as a screening tool